Physician profile
Kenneth Einberg
NPI 1972657534
$9,658.94
in general payments reported to CMS, 2019-2025
45 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $560 · 2021: $1,437 · 2022: $1,817 · 2023: $1,424 · 2024: $1,724 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,381.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,086.53 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $802.15 | 2019-2025 | Ultomiris |
| Biogen, INC. | $741.69 | 2019-2025 | Vumerity, Plegridy |
| Acadia Pharmaceuticals INC | $553.89 | 2019-2025 | Nuplazid |
| Ucb, INC. | $544.82 | 2019-2025 | Rystiggo |
| Lundbeck LLC | $485.62 | 2020-2025 | Vyepti |
| Neurocrine Biosciences, INC. | $481.20 | 2020-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $480.02 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Amneal Pharmaceuticals LLC | $462.84 | 2019-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Eisai INC. | $349.24 | 2023-2025 | |
| Upsher-Smith Laboratories LLC | $309.78 | 2019-2023 | |
| Amgen INC. | $269.17 | 2019-2022 | |
| Emd Serono, INC. | $182.31 | 2019-2023 | Mavenclad |
| Allergan, INC. | $173.27 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $160.60 | 2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Einberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.